Gonadal tumour screening in XY gonadal dysgenesis
Clinical Endocrinology · 2024-04 · 100 (4) · 366-367
DOI: 10.1111/cen.15015 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Endocrinology, online erschienen am 27.01.2024. Verfasst von Bruna Barbar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Royal Victoria Infirmary, Newcastle upon Tyne, UK. Hauptthemen laut MEDLINE: Gonadal Dysgenesis, 46,XY, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Endocrinology, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
- Department of Paediatric Endocrinology, Great North Children's Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
- Translational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
- Department of Metabolism, Digestion & Reproduction, Imperial College London, London, UK.
ORCID-Profile: Neomal De Silva, Richard Quinton
Förderung
- Medical Research Council
Zitieren
APA
Barbar, B., De Silva, N., Cheetham, T., Wood, C., & Quinton, R. (2024). Gonadal tumour screening in XY gonadal dysgenesis. Clinical Endocrinology, 100(4), 366-367. https://doi.org/10.1111/cen.15015
Vancouver
Barbar B, De Silva N, Cheetham T, Wood C, Quinton R. Gonadal tumour screening in XY gonadal dysgenesis. Clinical Endocrinology. 2024;100(4):366-367. doi:10.1111/cen.15015
BibTeX
@article{Barbar2024,
author = {Barbar, Bruna and De Silva, Neomal and Cheetham, Timothy and Wood, Claire and Quinton, Richard},
title = {Gonadal tumour screening in XY gonadal dysgenesis},
journal = {Clinical Endocrinology},
year = {2024},
volume = {100},
number = {4},
pages = {366--367},
doi = {10.1111/cen.15015}
}
EUVIMED